![]() |
Name |
chaetocochin A
|
Molecular Formula | C36H42N6O6S4 | |
IUPAC Name* |
(1S,11S,14S,19R,22S,25S)-22-(hydroxymethyl)-12,23,33-trimethyl-11,14,22,25-tetrakis(methylsulfanyl)-16-oxa-2,12,18,20,23,33-hexazaoctacyclo[16.8.6.211,14.12,9.01,19.03,8.020,25.027,32]pentatriaconta-3,5,7,9(35),27,29,31-heptaene-13,21,24,34-tetrone
|
|
SMILES |
CN1C(=O)[C@]2(COCN3[C@H]4[C@](C[C@]5(N4C(=O)[C@](N(C5=O)C)(CO)SC)SC)(C6=CC=CC=C63)N7C=C(C[C@@]1(C(=O)N2C)SC)C8=CC=CC=C87)SC
|
|
InChI |
InChI=1S/C36H42N6O6S4/c1-37-30(46)36(52-7)20-48-21-40-26-15-11-9-13-24(26)32(18-34(50-5)29(45)38(2)35(19-43,51-6)31(47)42(34)27(32)40)41-17-22(23-12-8-10-14-25(23)41)16-33(37,49-4)28(44)39(36)3/h8-15,17,27,43H,16,18-21H2,1-7H3/t27-,32+,33+,34+,35+,36+/m1/s1
|
|
InChIKey |
DOTYKRRRMXXIPL-ISYIGULMSA-N
|
|
Synonyms |
chaetocochin A; CHEMBL454044; (1S,11S,14S,19R,22S,25S)-22-(hydroxymethyl)-12,23,33-trimethyl-11,14,22,25-tetrakis(methylsulfanyl)-16-oxa-2,12,18,20,23,33-hexazaoctacyclo[16.8.6.211,14.12,9.01,19.03,8.020,25.027,32]pentatriaconta-3,5,7,9(35),27,29,31-heptaene-13,21,24,34-tetrone
|
|
CAS | NA | |
PubChem CID | 16086610 | |
ChEMBL ID | CHEMBL454044 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 783.0 | ALogp: | 3.6 |
HBD: | 1 | HBA: | 11 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 220.0 | Aromatic Rings: | 9 |
Heavy Atoms: | 52 | QED Weighted: | 0.408 |
Caco-2 Permeability: | -5.451 | MDCK Permeability: | 0.00001360 |
Pgp-inhibitor: | 0.99 | Pgp-substrate: | 0.779 |
Human Intestinal Absorption (HIA): | 0.783 | 20% Bioavailability (F20%): | 0.586 |
30% Bioavailability (F30%): | 0.91 |
Blood-Brain-Barrier Penetration (BBB): | 0.373 | Plasma Protein Binding (PPB): | 95.22% |
Volume Distribution (VD): | 1.661 | Fu: | 2.65% |
CYP1A2-inhibitor: | 0.014 | CYP1A2-substrate: | 0.58 |
CYP2C19-inhibitor: | 0.953 | CYP2C19-substrate: | 0.979 |
CYP2C9-inhibitor: | 0.962 | CYP2C9-substrate: | 0.111 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.017 |
CYP3A4-inhibitor: | 0.967 | CYP3A4-substrate: | 0.994 |
Clearance (CL): | 9.151 | Half-life (T1/2): | 0.004 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.803 |
Drug-inuced Liver Injury (DILI): | 0.996 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.802 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.909 | Carcinogencity: | 0.654 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.004 |
Respiratory Toxicity: | 0 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002348 | ![]() |
0.605 | D0V9WF | ![]() |
0.251 | ||
ENC004867 | ![]() |
0.605 | D01TSI | ![]() |
0.242 | ||
ENC002642 | ![]() |
0.497 | D0SP3D | ![]() |
0.237 | ||
ENC003978 | ![]() |
0.444 | D09NNH | ![]() |
0.236 | ||
ENC003455 | ![]() |
0.408 | D0V3ZA | ![]() |
0.236 | ||
ENC001500 | ![]() |
0.314 | D0R6RO | ![]() |
0.223 | ||
ENC004848 | ![]() |
0.313 | D02TJS | ![]() |
0.215 | ||
ENC005510 | ![]() |
0.304 | D07NVU | ![]() |
0.213 | ||
ENC003382 | ![]() |
0.297 | D01HTL | ![]() |
0.211 | ||
ENC003176 | ![]() |
0.295 | D02NEH | ![]() |
0.211 |